share_log
Benzinga ·  Apr 29 08:04
BioVie Awarded Up To $13.1M In Funding From US Department of Defense To Evaluate Bezisterim (NE3107) For Long COVID, The Study Is Expected To Start In Early 2025
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment